The global Nail Disorder Treatment Product market was valued at US$ 3857 million in 2025 and is anticipated to reach US$ 5589 million by 2032, at a CAGR of 5.7% from 2026 to 2032.

Nail Disorder Treatment Product Market

Nail Disorder Treatment Products are medications or medical devices designed to prevent, alleviate, or treat various nail-related disorders, including but not limited to fungal infections (onychomycosis), psoriasis, nail bed inflammation, and nail thickening or deformation. Mechanisms of action may include antifungal, anti-inflammatory, keratolytic, and nail regeneration-promoting effects. With lifestyle changes, an aging population, and increased awareness of health and aesthetics, the demand for nail disorder management continues to grow. These products involve not only clinical efficacy and safety validation but also considerations of indications, ease of use, patient adherence, and integration with overall skin health management, making them critical components of dermatology, podiatry, and cosmetic care.The average gross profit margin of this product is 55%.

The growth of the nail disorder treatment product market is driven by an aging population, increasing chronic conditions, and rising awareness of health and beauty. Older individuals and immunocompromised populations are more susceptible to fungal infections or nail thickening and deformation, increasing demand. Lifestyle changes and environmental factors have also made nail health issues more prevalent, further promoting product adoption. Pharmaceutical innovation and diversified product development, such as topical penetration technologies, nanocarriers, and combination oral-topical therapies, provide new growth opportunities. Consumers’ growing demand for safe, convenient, and effective home-care solutions is pushing companies to focus on personalized and experiential product offerings.

The market faces challenges including long treatment evaluation cycles, low patient adherence, and complex regulatory approvals. Nail disorder therapies typically require prolonged use, and patients may discontinue or adjust treatments independently, impacting efficacy assessment. Regulatory requirements differ across countries, particularly for combination oral and topical therapies, necessitating extensive safety and clinical data, which increases time to market. Additionally, product homogeneity and intense price competition may compress margins. Some consumers are concerned about chemical ingredients, driving interest in natural and plant-extract therapies but increasing R&D and validation costs.

Downstream demand shows trends toward professionalization, personalization, and home-based care. Dermatology and podiatry clinics increasingly seek highly effective and low-side-effect products, promoting development of clinically validated innovations. Cosmetic care and everyday health management are also focusing on nail health, driving home-care product adoption, particularly for convenient and safe topical formulations. The expansion of cross-border e-commerce and social media channels facilitates access to product information and purchasing, enhancing consumer focus on brand credibility and ingredient transparency. Overall, downstream demand is gradually shifting toward comprehensive care solutions and long-term management.

Upstream raw materials include active pharmaceutical ingredients (antifungal, anti-inflammatory, keratolytic), solvents, carrier systems, and excipients. The purity and stability of active ingredients directly affect efficacy and safety, representing key control points in R&D and production. Solvents and carriers ensure drug penetration into nails and nail beds and optimize bioavailability while meeting skin and mucosal safety standards. Excipients such as thickeners, moisturizers, and stabilizers are essential for product usability and physical stability. The upstream supply chain requires high-quality standards and traceable management to ensure regulatory compliance and product consistency.

This report delivers a comprehensive overview of the global Nail Disorder Treatment Product market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nail Disorder Treatment Product. The Nail Disorder Treatment Product market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Nail Disorder Treatment Product market comprehensively. Regional market sizes by Type, by Application, by Indication, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Nail Disorder Treatment Product manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Nail Disorder Treatment Product Market Report

Report Metric	Details
Report Name	Nail Disorder Treatment Product Market
Accounted market size in 2025	US$ 3857 million
Forecasted market size in 2032	US$ 5589 million
CAGR	5.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Topical Antifungal Drugs Systemic Antifungal Drugs Anti-inflammatory Nail Therapies Other
Segment by Indication	Onychomycosis Nail Psoriasis Ingrown Nails Nail Trauma
Segment by Product Type	Topical Drugs Oral Drugs Laser Therapy
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Bausch Health, Novartis, GSK, Sanofi, Bayer, Merck & Co., AstraZeneca, Europharma, CR Sanjiu, Taiji Group, Tonrentang, 3M Health Care, Galderma, Letai Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Indication, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Nail Disorder Treatment Product companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Nail Disorder Treatment Product Market growing?

Ans: The Nail Disorder Treatment Product Market witnessing a CAGR of 5.7% during the forecast period 2026-2032.

What is the Nail Disorder Treatment Product Market size in 2032?

Ans: The Nail Disorder Treatment Product Market size in 2032 will be US$ 5589 million.

Who are the main players in the Nail Disorder Treatment Product Market report?

Ans: The main players in the Nail Disorder Treatment Product Market are Pfizer, Bausch Health, Novartis, GSK, Sanofi, Bayer, Merck & Co., AstraZeneca, Europharma, CR Sanjiu, Taiji Group, Tonrentang, 3M Health Care, Galderma, Letai Pharma

What are the Application segmentation covered in the Nail Disorder Treatment Product Market report?

Ans: The Applications covered in the Nail Disorder Treatment Product Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Nail Disorder Treatment Product Market report?

Ans: The Types covered in the Nail Disorder Treatment Product Market report are Topical Drugs, Oral Drugs, Laser Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nail Disorder Treatment Product Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Topical Antifungal Drugs

1.2.3 Systemic Antifungal Drugs

1.2.4 Anti-inflammatory Nail Therapies

1.2.5 Other

1.3 Market by Indication

1.3.1 Global Nail Disorder Treatment Product Market Size Growth Rate by Indication: 2021 vs 2025 vs 2032

1.3.2 Onychomycosis

1.3.3 Nail Psoriasis

1.3.4 Ingrown Nails

1.3.5 Nail Trauma

1.4 Market by Product Type

1.4.1 Global Nail Disorder Treatment Product Market Size Growth Rate by Product Type: 2021 vs 2025 vs 2032

1.4.2 Topical Drugs

1.4.3 Oral Drugs

1.4.4 Laser Therapy

1.5 Market by Application

1.5.1 Global Nail Disorder Treatment Product Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Hospital

1.5.3 Retail Pharmacy

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Nail Disorder Treatment Product Market Perspective (2021–2032)

2.2 Global Nail Disorder Treatment Product Growth Trends by Region

2.2.1 Global Nail Disorder Treatment Product Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Nail Disorder Treatment Product Historic Market Size by Region (2021–2026)

2.2.3 Nail Disorder Treatment Product Forecasted Market Size by Region (2027–2032)

2.3 Nail Disorder Treatment Product Market Dynamics

2.3.1 Nail Disorder Treatment Product Industry Trends

2.3.2 Nail Disorder Treatment Product Market Drivers

2.3.3 Nail Disorder Treatment Product Market Challenges

2.3.4 Nail Disorder Treatment Product Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nail Disorder Treatment Product Players by Revenue

3.1.1 Global Top Nail Disorder Treatment Product Players by Revenue (2021–2026)

3.1.2 Global Nail Disorder Treatment Product Revenue Market Share by Players (2021–2026)

3.2 Global Top Nail Disorder Treatment Product Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Nail Disorder Treatment Product Revenue

3.4 Global Nail Disorder Treatment Product Market Concentration Ratio

3.4.1 Global Nail Disorder Treatment Product Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nail Disorder Treatment Product Revenue in 2025

3.5 Global Key Players of Nail Disorder Treatment Product Head Offices and Areas Served

3.6 Global Key Players of Nail Disorder Treatment Product, Products and Applications

3.7 Global Key Players of Nail Disorder Treatment Product, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Nail Disorder Treatment Product Breakdown Data by Type

4.1 Global Nail Disorder Treatment Product Historic Market Size by Type (2021–2026)

4.2 Global Nail Disorder Treatment Product Forecasted Market Size by Type (2027–2032)

5 Nail Disorder Treatment Product Breakdown Data by Application

5.1 Global Nail Disorder Treatment Product Historic Market Size by Application (2021–2026)

5.2 Global Nail Disorder Treatment Product Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Nail Disorder Treatment Product Market Size (2021–2032)

6.2 North America Nail Disorder Treatment Product Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Nail Disorder Treatment Product Market Size by Country (2021–2026)

6.4 North America Nail Disorder Treatment Product Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nail Disorder Treatment Product Market Size (2021–2032)

7.2 Europe Nail Disorder Treatment Product Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Nail Disorder Treatment Product Market Size by Country (2021–2026)

7.4 Europe Nail Disorder Treatment Product Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Nail Disorder Treatment Product Market Size (2021–2032)

8.2 Asia-Pacific Nail Disorder Treatment Product Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Nail Disorder Treatment Product Market Size by Region (2021–2026)

8.4 Asia-Pacific Nail Disorder Treatment Product Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Nail Disorder Treatment Product Market Size (2021–2032)

9.2 Latin America Nail Disorder Treatment Product Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Nail Disorder Treatment Product Market Size by Country (2021–2026)

9.4 Latin America Nail Disorder Treatment Product Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nail Disorder Treatment Product Market Size (2021–2032)

10.2 Middle East & Africa Nail Disorder Treatment Product Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Nail Disorder Treatment Product Market Size by Country (2021–2026)

10.4 Middle East & Africa Nail Disorder Treatment Product Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Nail Disorder Treatment Product Introduction

11.1.4 Pfizer Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.1.5 Pfizer Recent Development

11.2 Bausch Health

11.2.1 Bausch Health Company Details

11.2.2 Bausch Health Business Overview

11.2.3 Bausch Health Nail Disorder Treatment Product Introduction

11.2.4 Bausch Health Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.2.5 Bausch Health Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Nail Disorder Treatment Product Introduction

11.3.4 Novartis Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.3.5 Novartis Recent Development

11.4 GSK

11.4.1 GSK Company Details

11.4.2 GSK Business Overview

11.4.3 GSK Nail Disorder Treatment Product Introduction

11.4.4 GSK Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.4.5 GSK Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Nail Disorder Treatment Product Introduction

11.5.4 Sanofi Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.5.5 Sanofi Recent Development

11.6 Bayer

11.6.1 Bayer Company Details

11.6.2 Bayer Business Overview

11.6.3 Bayer Nail Disorder Treatment Product Introduction

11.6.4 Bayer Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.6.5 Bayer Recent Development

11.7 Merck & Co.

11.7.1 Merck & Co. Company Details

11.7.2 Merck & Co. Business Overview

11.7.3 Merck & Co. Nail Disorder Treatment Product Introduction

11.7.4 Merck & Co. Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.7.5 Merck & Co. Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Nail Disorder Treatment Product Introduction

11.8.4 AstraZeneca Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.8.5 AstraZeneca Recent Development

11.9 Europharma

11.9.1 Europharma Company Details

11.9.2 Europharma Business Overview

11.9.3 Europharma Nail Disorder Treatment Product Introduction

11.9.4 Europharma Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.9.5 Europharma Recent Development

11.10 CR Sanjiu

11.10.1 CR Sanjiu Company Details

11.10.2 CR Sanjiu Business Overview

11.10.3 CR Sanjiu Nail Disorder Treatment Product Introduction

11.10.4 CR Sanjiu Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.10.5 CR Sanjiu Recent Development

11.11 Taiji Group

11.11.1 Taiji Group Company Details

11.11.2 Taiji Group Business Overview

11.11.3 Taiji Group Nail Disorder Treatment Product Introduction

11.11.4 Taiji Group Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.11.5 Taiji Group Recent Development

11.12 Tonrentang

11.12.1 Tonrentang Company Details

11.12.2 Tonrentang Business Overview

11.12.3 Tonrentang Nail Disorder Treatment Product Introduction

11.12.4 Tonrentang Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.12.5 Tonrentang Recent Development

11.13 3M Health Care

11.13.1 3M Health Care Company Details

11.13.2 3M Health Care Business Overview

11.13.3 3M Health Care Nail Disorder Treatment Product Introduction

11.13.4 3M Health Care Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.13.5 3M Health Care Recent Development

11.14 Galderma

11.14.1 Galderma Company Details

11.14.2 Galderma Business Overview

11.14.3 Galderma Nail Disorder Treatment Product Introduction

11.14.4 Galderma Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.14.5 Galderma Recent Development

11.15 Letai Pharma

11.15.1 Letai Pharma Company Details

11.15.2 Letai Pharma Business Overview

11.15.3 Letai Pharma Nail Disorder Treatment Product Introduction

11.15.4 Letai Pharma Revenue in Nail Disorder Treatment Product Business (2021–2026)

11.15.5 Letai Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Nail Disorder Treatment Product Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Topical Antifungal Drugs

Table 3. Key Players of Systemic Antifungal Drugs

Table 4. Key Players of Anti-inflammatory Nail Therapies

Table 5. Key Players of Other

Table 6. Global Nail Disorder Treatment Product Market Size Growth Rate by Indication (US$ Million): 2021 vs 2025 vs 2032

Table 7. Key Players of Onychomycosis

Table 8. Key Players of Nail Psoriasis

Table 9. Key Players of Ingrown Nails

Table 10. Key Players of Nail Trauma

Table 11. Global Nail Disorder Treatment Product Market Size Growth Rate by Product Type (US$ Million): 2021 vs 2025 vs 2032

Table 12. Key Players of Topical Drugs

Table 13. Key Players of Oral Drugs

Table 14. Key Players of Laser Therapy

Table 15. Global Nail Disorder Treatment Product Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 16. Global Nail Disorder Treatment Product Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Nail Disorder Treatment Product Market Size by Region (US$ Million), 2021–2026

Table 18. Global Nail Disorder Treatment Product Market Share by Region (2021–2026)

Table 19. Global Nail Disorder Treatment Product Forecasted Market Size by Region (US$ Million), 2027–2032

Table 20. Global Nail Disorder Treatment Product Market Share by Region (2027–2032)

Table 21. Nail Disorder Treatment Product Market Trends

Table 22. Nail Disorder Treatment Product Market Drivers

Table 23. Nail Disorder Treatment Product Market Challenges

Table 24. Nail Disorder Treatment Product Market Restraints

Table 25. Global Nail Disorder Treatment Product Revenue by Players (US$ Million), 2021–2026

Table 26. Global Nail Disorder Treatment Product Market Share by Players (2021–2026)

Table 27. Global Top Nail Disorder Treatment Product Players by Tier (Tier 1, Tier 2, and Tier 3), based on Nail Disorder Treatment Product Revenue, 2025

Table 28. Ranking of Global Top Nail Disorder Treatment Product Companies by Revenue (US$ Million) in 2025

Table 29. Global 5 Largest Players Market Share by Nail Disorder Treatment Product Revenue (CR5 and HHI), 2021–2026

Table 30. Global Key Players of Nail Disorder Treatment Product, Headquarters and Area Served

Table 31. Global Key Players of Nail Disorder Treatment Product, Products and Applications

Table 32. Global Key Players of Nail Disorder Treatment Product, Date of General Availability (GA)

Table 33. Mergers and Acquisitions, Expansion Plans

Table 34. Global Nail Disorder Treatment Product Market Size by Type (US$ Million), 2021–2026

Table 35. Global Nail Disorder Treatment Product Revenue Market Share by Type (2021–2026)

Table 36. Global Nail Disorder Treatment Product Forecasted Market Size by Type (US$ Million), 2027–2032

Table 37. Global Nail Disorder Treatment Product Revenue Market Share by Type (2027–2032)

Table 38. Global Nail Disorder Treatment Product Market Size by Application (US$ Million), 2021–2026

Table 39. Global Nail Disorder Treatment Product Revenue Market Share by Application (2021–2026)

Table 40. Global Nail Disorder Treatment Product Forecasted Market Size by Application (US$ Million), 2027–2032

Table 41. Global Nail Disorder Treatment Product Revenue Market Share by Application (2027–2032)

Table 42. North America Nail Disorder Treatment Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. North America Nail Disorder Treatment Product Market Size by Country (US$ Million), 2021–2026

Table 44. North America Nail Disorder Treatment Product Market Size by Country (US$ Million), 2027–2032

Table 45. Europe Nail Disorder Treatment Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Europe Nail Disorder Treatment Product Market Size by Country (US$ Million), 2021–2026

Table 47. Europe Nail Disorder Treatment Product Market Size by Country (US$ Million), 2027–2032

Table 48. Asia-Pacific Nail Disorder Treatment Product Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 49. Asia-Pacific Nail Disorder Treatment Product Market Size by Region (US$ Million), 2021–2026

Table 50. Asia-Pacific Nail Disorder Treatment Product Market Size by Region (US$ Million), 2027–2032

Table 51. Latin America Nail Disorder Treatment Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Latin America Nail Disorder Treatment Product Market Size by Country (US$ Million), 2021–2026

Table 53. Latin America Nail Disorder Treatment Product Market Size by Country (US$ Million), 2027–2032

Table 54. Middle East & Africa Nail Disorder Treatment Product Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 55. Middle East & Africa Nail Disorder Treatment Product Market Size by Country (US$ Million), 2021–2026

Table 56. Middle East & Africa Nail Disorder Treatment Product Market Size by Country (US$ Million), 2027–2032

Table 57. Pfizer Company Details

Table 58. Pfizer Business Overview

Table 59. Pfizer Nail Disorder Treatment Product Product

Table 60. Pfizer Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 61. Pfizer Recent Development

Table 62. Bausch Health Company Details

Table 63. Bausch Health Business Overview

Table 64. Bausch Health Nail Disorder Treatment Product Product

Table 65. Bausch Health Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 66. Bausch Health Recent Development

Table 67. Novartis Company Details

Table 68. Novartis Business Overview

Table 69. Novartis Nail Disorder Treatment Product Product

Table 70. Novartis Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 71. Novartis Recent Development

Table 72. GSK Company Details

Table 73. GSK Business Overview

Table 74. GSK Nail Disorder Treatment Product Product

Table 75. GSK Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 76. GSK Recent Development

Table 77. Sanofi Company Details

Table 78. Sanofi Business Overview

Table 79. Sanofi Nail Disorder Treatment Product Product

Table 80. Sanofi Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 81. Sanofi Recent Development

Table 82. Bayer Company Details

Table 83. Bayer Business Overview

Table 84. Bayer Nail Disorder Treatment Product Product

Table 85. Bayer Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 86. Bayer Recent Development

Table 87. Merck & Co. Company Details

Table 88. Merck & Co. Business Overview

Table 89. Merck & Co. Nail Disorder Treatment Product Product

Table 90. Merck & Co. Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 91. Merck & Co. Recent Development

Table 92. AstraZeneca Company Details

Table 93. AstraZeneca Business Overview

Table 94. AstraZeneca Nail Disorder Treatment Product Product

Table 95. AstraZeneca Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 96. AstraZeneca Recent Development

Table 97. Europharma Company Details

Table 98. Europharma Business Overview

Table 99. Europharma Nail Disorder Treatment Product Product

Table 100. Europharma Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 101. Europharma Recent Development

Table 102. CR Sanjiu Company Details

Table 103. CR Sanjiu Business Overview

Table 104. CR Sanjiu Nail Disorder Treatment Product Product

Table 105. CR Sanjiu Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 106. CR Sanjiu Recent Development

Table 107. Taiji Group Company Details

Table 108. Taiji Group Business Overview

Table 109. Taiji Group Nail Disorder Treatment Product Product

Table 110. Taiji Group Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 111. Taiji Group Recent Development

Table 112. Tonrentang Company Details

Table 113. Tonrentang Business Overview

Table 114. Tonrentang Nail Disorder Treatment Product Product

Table 115. Tonrentang Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 116. Tonrentang Recent Development

Table 117. 3M Health Care Company Details

Table 118. 3M Health Care Business Overview

Table 119. 3M Health Care Nail Disorder Treatment Product Product

Table 120. 3M Health Care Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 121. 3M Health Care Recent Development

Table 122. Galderma Company Details

Table 123. Galderma Business Overview

Table 124. Galderma Nail Disorder Treatment Product Product

Table 125. Galderma Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 126. Galderma Recent Development

Table 127. Letai Pharma Company Details

Table 128. Letai Pharma Business Overview

Table 129. Letai Pharma Nail Disorder Treatment Product Product

Table 130. Letai Pharma Revenue in Nail Disorder Treatment Product Business (US$ Million), 2021–2026

Table 131. Letai Pharma Recent Development

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

Table 135. Authors List of This Report

List of Figures

Figure 1. Nail Disorder Treatment Product Picture

Figure 2. Global Nail Disorder Treatment Product Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Nail Disorder Treatment Product Market Share by Type: 2025 vs 2032

Figure 4. Topical Antifungal Drugs Features

Figure 5. Systemic Antifungal Drugs Features

Figure 6. Anti-inflammatory Nail Therapies Features

Figure 7. Other Features

Figure 8. Global Nail Disorder Treatment Product Market Size Comparison by Indication (US$ Million), 2021–2032

Figure 9. Onychomycosis Features

Figure 10. Nail Psoriasis Features

Figure 11. Ingrown Nails Features

Figure 12. Nail Trauma Features

Figure 13. Global Nail Disorder Treatment Product Market Size Comparison by Product Type (US$ Million), 2021–2032

Figure 14. Topical Drugs Features

Figure 15. Oral Drugs Features

Figure 16. Laser Therapy Features

Figure 17. Global Nail Disorder Treatment Product Market Size by Application (US$ Million), 2021–2032

Figure 18. Global Nail Disorder Treatment Product Market Share by Application: 2025 vs 2032

Figure 19. Hospital Case Studies

Figure 20. Retail Pharmacy Case Studies

Figure 21. Other Case Studies

Figure 22. Nail Disorder Treatment Product Report Years Considered

Figure 23. Global Nail Disorder Treatment Product Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 24. Global Nail Disorder Treatment Product Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global Nail Disorder Treatment Product Market Share by Region: 2025 vs 2032

Figure 26. Global Nail Disorder Treatment Product Market Share by Players in 2025

Figure 27. Global Nail Disorder Treatment Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by Nail Disorder Treatment Product Revenue in 2025

Figure 29. North America Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. North America Nail Disorder Treatment Product Market Share by Country (2021–2032)

Figure 31. United States Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Canada Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Europe Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe Nail Disorder Treatment Product Market Share by Country (2021–2032)

Figure 35. Germany Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. France Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. U.K. Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Italy Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Russia Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Ireland Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Asia-Pacific Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific Nail Disorder Treatment Product Market Share by Region (2021–2032)

Figure 43. China Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Japan Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. South Korea Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Southeast Asia Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. India Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Australia & New Zealand Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Latin America Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America Nail Disorder Treatment Product Market Share by Country (2021–2032)

Figure 51. Mexico Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Brazil Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Middle East & Africa Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa Nail Disorder Treatment Product Market Share by Country (2021–2032)

Figure 55. Israel Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Saudi Arabia Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. UAE Nail Disorder Treatment Product Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Pfizer Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 59. Bausch Health Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 60. Novartis Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 61. GSK Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 62. Sanofi Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 63. Bayer Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 64. Merck & Co. Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 65. AstraZeneca Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 66. Europharma Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 67. CR Sanjiu Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 68. Taiji Group Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 69. Tonrentang Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 70. 3M Health Care Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 71. Galderma Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 72. Letai Pharma Revenue Growth Rate in Nail Disorder Treatment Product Business (2021–2026)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions